Brain Monitoring Systems Market
Brain Monitoring Systems Market by Product, Modality, End User & Region | Forecast 2023 to 2033
Significant Opportunities are Being Established for Brain Monitoring Systems due to the Rising Incidence of Neurological Illnesses and the Growing Prevalence of Traumatic Brain Injury. FMI Taps the Global Market across 30+ Countries.
Brain Monitoring Systems Market Outlook (2023 to 2033)
The brain monitoring systems market is likely to record a CAGR of 5.5% during the forecast period. The market holds a share of US$ 5.0 billion in 2023, while it is anticipated to cross a value of US$ 8.5 billion by 2033.
The brain monitoring systems market outlook states that the increased healthcare budget post-pandemic is helping authorities to focus more on brain treatment procedures. The overall response to the advanced techniques provides real-time tracking of brain activity and response to the medication.
The market for brain monitoring systems is influenced by several macroeconomic and industrial factors, which include device regulations, device safety, and device licensing, as per the market dynamics originating from disease epidemiology and procedure adoption rates. These factors are anticipated to flourish the demand for brain monitoring systems globally.
The research report on the brain monitoring systems market explains that the brain functionality and its matrix are going through a research and development phase. Vendors now try to build devices that help each kind of patient in monitoring their EEG readings while using advanced scanning modules.
This advanced neuromonitoring includes synchronous video recording that clears the documentation and clears the EEG system. The integration of AI and Machine Learning along with cloud documentation is likely to transform brain scanning and monitoring procedures in the future. These elements of the fourth industrial revolution, Industry 4.0, have an overall impact on healthcare solutions. Brain tracking and monitoring devices prevent the patient from getting strokes or nerve damage as it constantly delivers information to the concerned doctor.
Attributes | Details |
---|---|
Brain Monitoring Systems Market CAGR (2023 to 2033) | 5.5% |
Brain Monitoring Systems Market Size (2023) | US$ 5.0 billion |
Brain Monitoring Systems Market Size (2033) | US$ 8.5 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
How is the Future Outlook for Brain Monitoring Systems Market in Comparison to the Historical Pattern?
Short-term Growth (2017 to 2022): The global brain monitoring systems market registered a CAGR of 7.0%. Brain monitoring systems are used in neurological testing for the detection of any abnormality in the functioning of brain cells (neurons) that leads to the development of neurological disorders such as Parkinson's disease, epilepsy, dementia, sleep disorder, and Alzheimer's. These systems allow the observation and identification of the activity of neurons without the need for invasive neurosurgery.
Mid-term Growth (2022 to 2028): The market has added new elements such as AI and machine learning into the picture during the mid-term growth period. However, the pandemic slowed down the research and development pace, which has been reflected in the current running forecast period. Furthermore, the advanced sensory technology that gathers most information about brain vitals is supposed to restore growth by the end of 2033.
Long-term Growth (2028 to 2033): These are mostly preferred for scanning anatomical pathologies in the brain and understanding the structural and functional activity of neurons. Brain monitoring systems form an integral part of neuroimaging and radiological procedures. Considering these factors, the market is projected to witness a CAGR of 5.5% to reach US$ 8.5 billion by 2033.
What are the Main Drivers of the Brain Monitoring Systems Market?
Rising Usage of Brain Monitoring Sensors in Integrated Healthcare
Through bidirectional data gathering and processing of EEG signals, brain monitoring sensors support clinicians in keeping track of the brain under the influence of anesthesia.
There is a growing need to monitor patients with traumatic brain injuries to prevent l brain damage, particularly cerebral ischemia. The increasing demand for assessing Increased Intracranial Pressure (ICP) in patient monitoring will propel the demand for brain monitoring sensors.
Invasive monitoring is a complicated, painful, and hazardous procedure because it requires direct involvement with gentle brain tissue. As a result, both doctors and patients are enthusiastic about the adoption of non-invasive or minimally invasive brain monitoring equipment.
Wireless monitors are devices that diagnose without the use of wires or cords. Wireless headphones enable fully non-invasive readings and, in some situations, assessment of patients from the comfort of their own homes.
The recording device can be disconnected from the computer and interact with it via wireless signals from a distance of up to 10 or 20 meters using wireless technology. These devices are easy to use, inexpensive, and simple to maintain, and they only require one AAA battery. Handheld brain monitoring devices are small, light, and convenient to carry in one's hand.
Which Factors are Negatively Affecting Demand for Brain Monitoring Systems?
The high Cost of Brain Monitoring Devices and Surgeries limit the Market Growth
Lack of essential healthcare infrastructure, high treatment costs, and safety concerns about implant applications may all act as roadblocks to the expansion of the brain monitoring devices industry. Methods involving these devices are often costly, and equipment is considerably complicated. Product uptake may be hampered by the presence of negative reimbursement schemes and government laws.
Comparative View of Brain Monitoring Systems Market
Brain Monitoring Systems Market:
Attributes | Brain Monitoring Systems Market |
---|---|
CAGR (2023 to 2033) | 5.5% |
Market Value (2033) | US$ 8.5 billion |
Growth Factor | The higher number of diseases related to brain injuries and brain paralysis is expanding the brain monitoring systems market size. |
Opportunity | The higher adoption of customized brain monitoring systems is creating opportunities for the market. |
Key Trends | Real-time EEG tracking along with anesthesia monitoring is shaping the trends in the market. |
Medical Devices Market:
Attributes | Medical devises Market |
---|---|
CAGR (2023 to 2033) | 12.11% |
Market Value (2033) | US$ 976.86 million |
Growth Factor | Rising cases of epilepsy, Parkinson, and Alzheimer along with advanced technology are fueling the demand for wearable brain devices. |
Opportunity | Stroke-prone patients’ higher consumption of wearable brain devices is creating opportunities for the market. |
Key Trends | Increased clinical studies on wearable healthcare equipment are shaping the market trend. |
Brain-Computer Interface Market:
Attributes | Brain-Computer Interface Market |
---|---|
CAGR (2023 to 2033) | 16.9% |
Market Value (2033) | US$ 39.28 billion |
Growth Factor | Common brain injuries or diseases like Parkinson's are penetrating high in the urban population, flourishing the adoption of brain-computer interface/ |
Opportunity | Apart from clinical usage, the technology is used in virtual gaming along with military communication systems. |
Key Trends | Its usage in smart home appliances is shaping the trends for brain-computer interface systems. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Brain Monitoring Systems Market Country-wise Insights
Region | Absolute Market Growth |
---|---|
The United States | US$ 1.3 billion |
The United Kingdom | US$ 59.2 million |
China | US$ 472.1 million |
Japan | US$ 245.5 million |
India | US$ 244.9 million |
Which Region leads the Market in terms of Market Share?
Rising Prevalence of Neurological Diseases to Fuel Sales of Brain Monitoring Products in the United States
Region | Attributes |
---|---|
The United States Market CAGR (2023 to 2033) | 6.4% |
The United States Market Absolute Doller Growth (US$ million/billion) | US$ 1.3 billion |
According to the National Institute of Neurological Disorders and Stroke, nearly 30 million people in the United States suffer from one of the nearly 7,000 identified uncommon or ultra-rare disorders. Over 45% of uncommon diseases are associated with neurological symptoms. In the United States, the rising prevalence of various neurodegenerative and neurological disorders has led to increased innovation in mobile EEG devices, real-time monitoring, and alarms. Hence the demand for brain monitoring products is increasing. The United States is likely to cross a market share of US$ 2.7 billion by 2033.
What makes China the Leading Market in terms of CAGR?
Rapid Deployment of Non-invasive Brain Monitoring Devices in the Country
Region | Attributes |
---|---|
Market in China CAGR (2023 to 2033) | 7.6% |
Market in China Absolute Doller Growth (US$ million/billion) | US$ 472.1 million |
China is anticipated to be the hotspot destination for investment opportunities for key players. It is due to the high diagnosis growth rate, research activities, quality improvisations, and increasing healthcare modernization. An increase in the number of senior citizens and patients with severe diseases, a rise in consumer spending, and the growing adoption of non-invasive brain monitoring devices are driving the market growth in China. The market in China is expected to reach a market valuation of US$ 905.9 million.
How will the Brain Monitoring Systems Market Expand across Japan?
Region | Attributes |
---|---|
Market in Japan CAGR (2023 to 2033) | 5.9% |
Market in Japan Absolute Doller Growth (US$ million/billion) | US$ 245.5 million |
The brain monitoring system market in Japan is growing due to the rising prevalence of neurological illnesses and the availability of medical reimbursements. Higher healthcare spending and a more advanced healthcare infrastructure will contribute to an increase in demand for brain monitoring devices in the region.
An increased number of clinical trials for advanced brain monitoring technologies has been directed by the growing government financing for neuroscience. Another impact-rendering driver for market growth is the wide availability of insurance coverage. The market is expected to reach a value of US$ 563.9 million.
Category-wise Insights
Segment | Top Product Type |
---|---|
Top Sub-segment | EEG Systems |
CAGR (2018 to 2022) | 7.8% |
CAGR (2023 to 2033) | 6.2% |
Segment | Top Modality |
---|---|
Top Sub-segment | Standalone |
CAGR (2018 to 2022) | 6.8% |
CAGR (2023 to 2033) | 5.1% |
Focus on Delivering Effective Treatment via Early Detection of Abnormalities Driving Adoption of EEG Systems.
Monitoring of neural signals along the scalp caused by the activation of neurons in the brain is known as Electroencephalography (EEG). EEG is a term used in clinical settings to describe the tracking of the brain's natural electrical stimulation during a short period, often 20-40 minutes, using many electrodes on the scalp.
The most common use of EEG systems in neurology is to diagnose epilepsy, as epileptic activity can cause obvious abnormalities in a regular EEG study. EEG systems are also used in the detection of unconsciousness, dementia, and brain death as a secondary clinical application.
The use of EEG machines has been fuelled by a desire to provide successful therapy through the early detection of problems, as this equipment allows for helpful therapies with minimal risk of neurological consequences. The EEG system segment is recording a CAGR of 6.2% during the forecast period.
Higher Portability Makes the Standalone Brain Monitoring System the First Choice
The changing lifestyle and advanced battery-based brain monitoring systems are gaining traction for standalone systems by modality. Expanding in the market, vendors design these standalone systems efficiently. These systems also work on the same EEG measures that track the patterns of electrical activity in the brain. The segment records a CAGR of 5.1% between 2023 and 2033.
Significant Increase in Usage of EEG Standard & MRI Systems for Brain Monitoring across Hospitals
Hospitals accounted for a 42.1% share of the brain monitoring systems market in 2022. Brain monitoring is a complicated procedure that necessitates the use of costly and advanced technology and systems usually available in hospitals.
Compared to small clinics and other end users, hospitals experience a significantly higher intake of patients. Brain monitoring devices put a significant financial strain on healthcare facilities in terms of maintenance expenditures; hospitals can tolerate such expenses. As a result, the majority of brain monitoring devices are utilized in hospitals.
Competition Scenario
Key manufacturers of brain monitoring systems are focusing on marketing strategies to increase both their product portfolio as well as geographical presence.
Some other key market strategies followed by manufacturers include distribution & collaboration agreements to increase product reach, partnering with local as well as global retailers, and long-term partnerships with ambulatory surgical centers, clinics, hospitals and other distribution channels such as neonatal and pediatrics ICUs.
For instance:
In November 2021, Medtronic PLC., teamed up with Rune Labs, a leading supplier of neurological and psychiatric disease solutions, to leverage the latter's proprietary software system to integrate, analyze, and visualize information from its Percept PC Neurostimulator.
Major Contributors of the Brain Monitoring Systems Market are
- Neurosoft
- Natus Medical Incorporated
- Medtronic PLC
- Integra Lifesciences
- Compumedics Neuroscan
- Masimo Corporation
- Elekta AB
- Advanced Brain Monitoring Inc.
- Cadwell Laboratories
- Nonin Medical Inc.
- Nihon Kohden Corporation
Key Segments
Brain Monitoring Systems Market by Product:
- fNIRS
- EEG Systems
- MEG Systems
- MRI Systems
- Others
Brain Monitoring Systems Market by Modality:
- Portable/Handheld Brain Monitoring Systems
- Standalone Brain Monitoring Systems
Brain Monitoring Systems Market by End User:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
- Pediatric & Neonatal Intensive Care Units
By Region:
- North America
- Latin America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
Frequently Asked Questions
How Big is the Brain Monitoring Systems Market?
The market is valued at US$ 5.0 billion in 2023.
What is the Growth Forecast for the Brain Monitoring Systems Market?
The market is forecast to register a CAGR of 5.5% through 2033.
What was the Historical Market Growth Outlook?
From 2017 to 2022, the market secured a CAGR of 7.0%.
What is the Expected Size of the Market by 2033?
By 2033, the market is estimated to reach US$ 8.5 billion.
What is the CAGR of China’s Market?
China’s market is expected to surge at a 7.6% CAGR.
Table of Content
1. Executive Summary | Brain Monitoring Systems Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyers 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product Type, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. MRI Systems 5.3.1.1. fMRI Systems 5.3.1.2. Others MRI Systems 5.3.2. EEG Systems 5.3.2.1. Simplified EEG Systems 5.3.2.2. Other EEG Systems 5.3.3. MEG Systems 5.3.4. fNIRS Systems 5.3.5. Other Systems 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Modality 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Modality, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Modality, 2023 to 2033 6.3.1. Portable/ Handheld 6.3.2. Standalone 6.4. Y-o-Y Growth Trend Analysis By Modality, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Modality, 2023 to 2033 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033 7.3.1. Hospitals 7.3.2. Ambulatory Surgical Systems 7.3.3. Clinics 7.3.4. Pediatric & Neonatal ICUS 7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022 7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033 8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. Asia Pacific Excluding Japan 8.3.6. Japan 8.3.7. Middle East & Africa (MEA) 8.4. Market Attractiveness Analysis By Region 9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Modality 9.2.4. By End User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Modality 9.3.4. By End User 9.4. Key Takeaways 10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Modality 10.2.4. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Modality 10.3.4. By End User 10.4. Key Takeaways 11. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. UK 11.2.1.5. Spain 11.2.1.6. Benelux 11.2.1.7. Nordic 11.2.1.8. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Modality 11.2.4. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Modality 11.3.4. By End User 11.4. Key Takeaways 12. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Russia 12.2.1.2. Poland 12.2.1.3. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Modality 12.2.4. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Modality 12.3.4. By End User 12.4. Key Takeaways 13. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. ANZ 13.2.1.3. India 13.2.1.4. Association of Southeast Asian Nations 13.2.1.5. Rest of APEJ 13.2.2. By Product Type 13.2.3. By Modality 13.2.4. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Modality 13.3.4. By End User 13.4. Key Takeaways 14. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.2. By Product Type 14.2.3. By Modality 14.2.4. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Modality 14.3.4. By End User 14.4. Key Takeaways 15. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. North Africa 15.2.1.3. South Africa 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Modality 15.2.4. By End User 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Modality 15.3.4. By End User 15.4. Key Takeaways 16. Key Countries Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Modality 16.1.2.3. By End User 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Modality 16.2.2.3. By End User 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Modality 16.3.2.3. By End User 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Modality 16.4.2.3. By End User 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Modality 16.5.2.3. By End User 16.6. Germany 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Modality 16.6.2.3. By End User 16.7. Italy 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Modality 16.7.2.3. By End User 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Modality 16.8.2.3. By End User 16.9. UK 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Modality 16.9.2.3. By End User 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Modality 16.10.2.3. By End User 16.11. Benelux 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Modality 16.11.2.3. By End User 16.12. Nordic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Modality 16.12.2.3. By End User 16.13. Russia 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Modality 16.13.2.3. By End User 16.14. Poland 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Modality 16.14.2.3. By End User 16.15. China 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Modality 16.15.2.3. By End User 16.16. ANZ 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Modality 16.16.2.3. By End User 16.17. India 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Modality 16.17.2.3. By End User 16.18. Association of Southeast Asian Nations 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Modality 16.18.2.3. By End User 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Modality 16.19.2.3. By End User 16.20. GCC Countries 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Modality 16.20.2.3. By End User 16.21. North Africa 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Modality 16.21.2.3. By End User 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Modality 16.22.2.3. By End User 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Modality 17.3.4. By End User 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Neurosoft 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. Natus Medical Incorporated 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. Medtronic PLC 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Integra Lifesciences 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Compumedics Neuroscan 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Masimo Corporation 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Elekta AB 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Advanced Brain Monitoring Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Cadwell Laboratories 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Nonin Medical Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Nihon Kohden Corporation 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Value (US$ Million) Forecast by Region, 2017 to 2033 Table 2: Global Volume (Units) Forecast by Region, 2017 to 2033 Table 3: Global Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 4: Global Volume (Units) Forecast by Product Type, 2017 to 2033 Table 5: Global Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 6: Global Volume (Units) Forecast by Modality, 2017 to 2033 Table 7: Global Value (US$ Million) Forecast by End User, 2017 to 2033 Table 8: Global Volume (Units) Forecast by End User, 2017 to 2033 Table 9: North America Value (US$ Million) Forecast by Country, 2017 to 2033 Table 10: North America Volume (Units) Forecast by Country, 2017 to 2033 Table 11: North America Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 12: North America Volume (Units) Forecast by Product Type, 2017 to 2033 Table 13: North America Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 14: North America Volume (Units) Forecast by Modality, 2017 to 2033 Table 15: North America Value (US$ Million) Forecast by End User, 2017 to 2033 Table 16: North America Volume (Units) Forecast by End User, 2017 to 2033 Table 17: Latin America Value (US$ Million) Forecast by Country, 2017 to 2033 Table 18: Latin America Volume (Units) Forecast by Country, 2017 to 2033 Table 19: Latin America Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 20: Latin America Volume (Units) Forecast by Product Type, 2017 to 2033 Table 21: Latin America Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 22: Latin America Volume (Units) Forecast by Modality, 2017 to 2033 Table 23: Latin America Value (US$ Million) Forecast by End User, 2017 to 2033 Table 24: Latin America Volume (Units) Forecast by End User, 2017 to 2033 Table 25: Western Europe Value (US$ Million) Forecast by Country, 2017 to 2033 Table 26: Western Europe Volume (Units) Forecast by Country, 2017 to 2033 Table 27: Western Europe Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 28: Western Europe Volume (Units) Forecast by Product Type, 2017 to 2033 Table 29: Western Europe Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 30: Western Europe Volume (Units) Forecast by Modality, 2017 to 2033 Table 31: Western Europe Value (US$ Million) Forecast by End User, 2017 to 2033 Table 32: Western Europe Volume (Units) Forecast by End User, 2017 to 2033 Table 33: Eastern Europe Value (US$ Million) Forecast by Country, 2017 to 2033 Table 34: Eastern Europe Volume (Units) Forecast by Country, 2017 to 2033 Table 35: Eastern Europe Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 36: Eastern Europe Volume (Units) Forecast by Product Type, 2017 to 2033 Table 37: Eastern Europe Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 38: Eastern Europe Volume (Units) Forecast by Modality, 2017 to 2033 Table 39: Eastern Europe Value (US$ Million) Forecast by End User, 2017 to 2033 Table 40: Eastern Europe Volume (Units) Forecast by End User, 2017 to 2033 Table 41: APEJ Value (US$ Million) Forecast by Country, 2017 to 2033 Table 42: APEJ Volume (Units) Forecast by Country, 2017 to 2033 Table 43: APEJ Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 44: APEJ Volume (Units) Forecast by Product Type, 2017 to 2033 Table 45: APEJ Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 46: APEJ Volume (Units) Forecast by Modality, 2017 to 2033 Table 47: APEJ Value (US$ Million) Forecast by End User, 2017 to 2033 Table 48: APEJ Volume (Units) Forecast by End User, 2017 to 2033 Table 49: Japan Value (US$ Million) Forecast by Country, 2017 to 2033 Table 50: Japan Volume (Units) Forecast by Country, 2017 to 2033 Table 51: Japan Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 52: Japan Volume (Units) Forecast by Product Type, 2017 to 2033 Table 53: Japan Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 54: Japan Volume (Units) Forecast by Modality, 2017 to 2033 Table 55: Japan Value (US$ Million) Forecast by End User, 2017 to 2033 Table 56: Japan Volume (Units) Forecast by End User, 2017 to 2033 Table 57: MEA Value (US$ Million) Forecast by Country, 2017 to 2033 Table 58: MEA Volume (Units) Forecast by Country, 2017 to 2033 Table 59: MEA Value (US$ Million) Forecast by Product Type, 2017 to 2033 Table 60: MEA Volume (Units) Forecast by Product Type, 2017 to 2033 Table 61: MEA Value (US$ Million) Forecast by Modality, 2017 to 2033 Table 62: MEA Volume (Units) Forecast by Modality, 2017 to 2033 Table 63: MEA Value (US$ Million) Forecast by End User, 2017 to 2033 Table 64: MEA Volume (Units) Forecast by End User, 2017 to 2033
List of Charts
Figure 1: Global Value (US$ Million) by Product Type, 2023 to 2033 Figure 2: Global Value (US$ Million) by Modality, 2023 to 2033 Figure 3: Global Value (US$ Million) by End User, 2023 to 2033 Figure 4: Global Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Value (US$ Million) Analysis by Region, 2017 to 2033 Figure 6: Global Volume (Units) Analysis by Region, 2017 to 2033 Figure 7: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 8: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 9: Global Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 10: Global Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 11: Global Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 12: Global Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 13: Global Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 14: Global Volume (Units) Analysis by Modality, 2017 to 2033 Figure 15: Global Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 16: Global Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 17: Global Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 18: Global Volume (Units) Analysis by End User, 2017 to 2033 Figure 19: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 20: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 21: Global Attractiveness by Product Type, 2023 to 2033 Figure 22: Global Attractiveness by Modality, 2023 to 2033 Figure 23: Global Attractiveness by End User, 2023 to 2033 Figure 24: Global Attractiveness by Region, 2023 to 2033 Figure 25: North America Value (US$ Million) by Product Type, 2023 to 2033 Figure 26: North America Value (US$ Million) by Modality, 2023 to 2033 Figure 27: North America Value (US$ Million) by End User, 2023 to 2033 Figure 28: North America Value (US$ Million) by Country, 2023 to 2033 Figure 29: North America Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 30: North America Volume (Units) Analysis by Country, 2017 to 2033 Figure 31: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 32: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 33: North America Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 34: North America Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 35: North America Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 36: North America Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 37: North America Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 38: North America Volume (Units) Analysis by Modality, 2017 to 2033 Figure 39: North America Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 40: North America Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 41: North America Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 42: North America Volume (Units) Analysis by End User, 2017 to 2033 Figure 43: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 44: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 45: North America Attractiveness by Product Type, 2023 to 2033 Figure 46: North America Attractiveness by Modality, 2023 to 2033 Figure 47: North America Attractiveness by End User, 2023 to 2033 Figure 48: North America Attractiveness by Country, 2023 to 2033 Figure 49: Latin America Value (US$ Million) by Product Type, 2023 to 2033 Figure 50: Latin America Value (US$ Million) by Modality, 2023 to 2033 Figure 51: Latin America Value (US$ Million) by End User, 2023 to 2033 Figure 52: Latin America Value (US$ Million) by Country, 2023 to 2033 Figure 53: Latin America Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 54: Latin America Volume (Units) Analysis by Country, 2017 to 2033 Figure 55: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 56: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 57: Latin America Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 58: Latin America Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 59: Latin America Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 60: Latin America Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 61: Latin America Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 62: Latin America Volume (Units) Analysis by Modality, 2017 to 2033 Figure 63: Latin America Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 64: Latin America Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 65: Latin America Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 66: Latin America Volume (Units) Analysis by End User, 2017 to 2033 Figure 67: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 68: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 69: Latin America Attractiveness by Product Type, 2023 to 2033 Figure 70: Latin America Attractiveness by Modality, 2023 to 2033 Figure 71: Latin America Attractiveness by End User, 2023 to 2033 Figure 72: Latin America Attractiveness by Country, 2023 to 2033 Figure 73: Western Europe Value (US$ Million) by Product Type, 2023 to 2033 Figure 74: Western Europe Value (US$ Million) by Modality, 2023 to 2033 Figure 75: Western Europe Value (US$ Million) by End User, 2023 to 2033 Figure 76: Western Europe Value (US$ Million) by Country, 2023 to 2033 Figure 77: Western Europe Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 78: Western Europe Volume (Units) Analysis by Country, 2017 to 2033 Figure 79: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 80: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 81: Western Europe Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 82: Western Europe Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 83: Western Europe Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 84: Western Europe Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 85: Western Europe Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 86: Western Europe Volume (Units) Analysis by Modality, 2017 to 2033 Figure 87: Western Europe Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 88: Western Europe Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 89: Western Europe Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 90: Western Europe Volume (Units) Analysis by End User, 2017 to 2033 Figure 91: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 92: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 93: Western Europe Attractiveness by Product Type, 2023 to 2033 Figure 94: Western Europe Attractiveness by Modality, 2023 to 2033 Figure 95: Western Europe Attractiveness by End User, 2023 to 2033 Figure 96: Western Europe Attractiveness by Country, 2023 to 2033 Figure 97: Eastern Europe Value (US$ Million) by Product Type, 2023 to 2033 Figure 98: Eastern Europe Value (US$ Million) by Modality, 2023 to 2033 Figure 99: Eastern Europe Value (US$ Million) by End User, 2023 to 2033 Figure 100: Eastern Europe Value (US$ Million) by Country, 2023 to 2033 Figure 101: Eastern Europe Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 102: Eastern Europe Volume (Units) Analysis by Country, 2017 to 2033 Figure 103: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 104: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 105: Eastern Europe Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 106: Eastern Europe Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 107: Eastern Europe Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 108: Eastern Europe Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 109: Eastern Europe Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 110: Eastern Europe Volume (Units) Analysis by Modality, 2017 to 2033 Figure 111: Eastern Europe Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 112: Eastern Europe Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 113: Eastern Europe Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 114: Eastern Europe Volume (Units) Analysis by End User, 2017 to 2033 Figure 115: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 116: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 117: Eastern Europe Attractiveness by Product Type, 2023 to 2033 Figure 118: Eastern Europe Attractiveness by Modality, 2023 to 2033 Figure 119: Eastern Europe Attractiveness by End User, 2023 to 2033 Figure 120: Eastern Europe Attractiveness by Country, 2023 to 2033 Figure 121: APEJ Value (US$ Million) by Product Type, 2023 to 2033 Figure 122: APEJ Value (US$ Million) by Modality, 2023 to 2033 Figure 123: APEJ Value (US$ Million) by End User, 2023 to 2033 Figure 124: APEJ Value (US$ Million) by Country, 2023 to 2033 Figure 125: APEJ Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 126: APEJ Volume (Units) Analysis by Country, 2017 to 2033 Figure 127: APEJ Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 128: APEJ Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 129: APEJ Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 130: APEJ Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 131: APEJ Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 132: APEJ Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 133: APEJ Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 134: APEJ Volume (Units) Analysis by Modality, 2017 to 2033 Figure 135: APEJ Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 136: APEJ Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 137: APEJ Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 138: APEJ Volume (Units) Analysis by End User, 2017 to 2033 Figure 139: APEJ Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 140: APEJ Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 141: APEJ Attractiveness by Product Type, 2023 to 2033 Figure 142: APEJ Attractiveness by Modality, 2023 to 2033 Figure 143: APEJ Attractiveness by End User, 2023 to 2033 Figure 144: APEJ Attractiveness by Country, 2023 to 2033 Figure 145: Japan Value (US$ Million) by Product Type, 2023 to 2033 Figure 146: Japan Value (US$ Million) by Modality, 2023 to 2033 Figure 147: Japan Value (US$ Million) by End User, 2023 to 2033 Figure 148: Japan Value (US$ Million) by Country, 2023 to 2033 Figure 149: Japan Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 150: Japan Volume (Units) Analysis by Country, 2017 to 2033 Figure 151: Japan Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 152: Japan Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 153: Japan Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 154: Japan Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 155: Japan Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 156: Japan Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 157: Japan Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 158: Japan Volume (Units) Analysis by Modality, 2017 to 2033 Figure 159: Japan Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 160: Japan Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 161: Japan Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 162: Japan Volume (Units) Analysis by End User, 2017 to 2033 Figure 163: Japan Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 164: Japan Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 165: Japan Attractiveness by Product Type, 2023 to 2033 Figure 166: Japan Attractiveness by Modality, 2023 to 2033 Figure 167: Japan Attractiveness by End User, 2023 to 2033 Figure 168: Japan Attractiveness by Country, 2023 to 2033 Figure 169: MEA Value (US$ Million) by Product Type, 2023 to 2033 Figure 170: MEA Value (US$ Million) by Modality, 2023 to 2033 Figure 171: MEA Value (US$ Million) by End User, 2023 to 2033 Figure 172: MEA Value (US$ Million) by Country, 2023 to 2033 Figure 173: MEA Value (US$ Million) Analysis by Country, 2017 to 2033 Figure 174: MEA Volume (Units) Analysis by Country, 2017 to 2033 Figure 175: MEA Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 176: MEA Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 177: MEA Value (US$ Million) Analysis by Product Type, 2017 to 2033 Figure 178: MEA Volume (Units) Analysis by Product Type, 2017 to 2033 Figure 179: MEA Value Share (%) and BPS Analysis by Product Type, 2023 to 2033 Figure 180: MEA Y-o-Y Growth (%) Projections by Product Type, 2023 to 2033 Figure 181: MEA Value (US$ Million) Analysis by Modality, 2017 to 2033 Figure 182: MEA Volume (Units) Analysis by Modality, 2017 to 2033 Figure 183: MEA Value Share (%) and BPS Analysis by Modality, 2023 to 2033 Figure 184: MEA Y-o-Y Growth (%) Projections by Modality, 2023 to 2033 Figure 185: MEA Value (US$ Million) Analysis by End User, 2017 to 2033 Figure 186: MEA Volume (Units) Analysis by End User, 2017 to 2033 Figure 187: MEA Value Share (%) and BPS Analysis by End User, 2023 to 2033 Figure 188: MEA Y-o-Y Growth (%) Projections by End User, 2023 to 2033 Figure 189: MEA Attractiveness by Product Type, 2023 to 2033 Figure 190: MEA Attractiveness by Modality, 2023 to 2033 Figure 191: MEA Attractiveness by End User, 2023 to 2033 Figure 192: MEA Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports